112 related articles for article (PubMed ID: 2345596)
1. Enalapril improved renal function and proteinuria in chronic glomerulopathies.
Ferder LF; Inserra F; Daccordi H; Smith RD
Nephron; 1990; 55 Suppl 1():90-5. PubMed ID: 2345596
[TBL] [Abstract][Full Text] [Related]
2. Effects of enalapril on renal parameters in patients with primary glomerulopathies associated with chronic renal failure.
Ferder LF; Inserra F; Daccordi H; Romano L; Fernández A; Tessler J
Drugs; 1990; 39 Suppl 2():40-6. PubMed ID: 2344817
[TBL] [Abstract][Full Text] [Related]
3. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
Tylicki L; Rutkowski P; Renke M; Rutkowski B
Am J Nephrol; 2002; 22(4):356-62. PubMed ID: 12169868
[TBL] [Abstract][Full Text] [Related]
4. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
Giri S; Mahajan SK; Sen R; Sharma A
J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207
[TBL] [Abstract][Full Text] [Related]
5. The effect of enalapril on proteinuria in patients with chronic glomerulonephritis and renal insufficiency.
Yoshida A; Morozumi K; Takeda A; Koyama K; Ideura T; Ikeda M; Oikawa T
Nihon Jinzo Gakkai Shi; 1993 Nov; 35(11):1249-52. PubMed ID: 8139137
[TBL] [Abstract][Full Text] [Related]
6. [Effect of ACE inhibitors on proteinuria and renal functioning in primary glomerulopathies].
Boratyńska M; Mazanowska O; Szewczyk Z; Czyz W
Pol Tyg Lek; 1992 Dec 7-14; 47(49-50):1090-2. PubMed ID: 1305732
[TBL] [Abstract][Full Text] [Related]
7. Etiology of increased enzymuria in different morphological forms of glomerulonephritis.
Kuźniar J; Marchewka Z; Lembas-Bogaczyk J; Kuźniar TJ; Klinger M
Nephron Physiol; 2004; 98(1):p8-14. PubMed ID: 15503426
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and renal effects of enalapril therapy for hypertensive patients with chronic renal insufficiency.
Abraham PA; Opsahl JA; Halstenson CE; Keane WF
Arch Intern Med; 1988 Nov; 148(11):2358-62. PubMed ID: 2847667
[TBL] [Abstract][Full Text] [Related]
9. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
[TBL] [Abstract][Full Text] [Related]
10. Effect of enalapril on proteinuria and renal function in patients with healed severe crescentic glomerulonephritis.
Leaker B; Neild GH
Nephrol Dial Transplant; 1991; 6(12):936-8. PubMed ID: 1798592
[TBL] [Abstract][Full Text] [Related]
11. Enalapril can treat the proteinuria of membranous glomerulonephritis without detriment to systemic or renal hemodynamics.
Thomas DM; Hillis AN; Coles GA; Davies M; Williams JD
Am J Kidney Dis; 1991 Jul; 18(1):38-43. PubMed ID: 1712151
[TBL] [Abstract][Full Text] [Related]
12. [Nicardipine, alone or in combination with enalapril, in the therapy of arterial hypertension secondary to chronic nephropathy].
Pecci G; Feriozzi S; Morabito S; Mavrikakis G; Roscia E; Simonetti BM; Pierucci A
Clin Ter; 1989 Sep; 130(6):327-32. PubMed ID: 2572374
[TBL] [Abstract][Full Text] [Related]
13. ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis.
Woo KT; Lau YK; Wong KS; Chiang GS
Kidney Int; 2000 Dec; 58(6):2485-91. PubMed ID: 11115082
[TBL] [Abstract][Full Text] [Related]
14. [The effect of the angiotensin-converting enzyme inhibitor enalapril on the rates of progression of chronic kidney failure in patients with different degrees of functional kidney disorders].
Esaian AM; Kaiukov IG; Titova VA
Ter Arkh; 1995; 67(6):57-9. PubMed ID: 7667785
[TBL] [Abstract][Full Text] [Related]
15. DNA fragmentation in chronic glomerulonephritis: an immunohistological analysis.
Ott U; Aschoff A; Pocock J; Fünfstück R; Jirikowski G; Stein G; Wolf G
Nephron Clin Pract; 2007; 105(1):c18-28. PubMed ID: 17114899
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of enalapril in the treatment of steroid resistant idiopathic nephrotic syndrome.
Prasher PK; Varma PP; Baliga KV
J Assoc Physicians India; 1999 Feb; 47(2):180-2. PubMed ID: 10999084
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme.
Falk RJ; Scheinman J; Phillips G; Orringer E; Johnson A; Jennette JC
N Engl J Med; 1992 Apr; 326(14):910-5. PubMed ID: 1542341
[TBL] [Abstract][Full Text] [Related]
18. [Long-term effect of angiotensin-converting inhibitors in children with proteinuria].
Camacho Díaz JA; Giménez Llort A; García García L; Jiménez González R
An Esp Pediatr; 2001 Sep; 55(3):219-24. PubMed ID: 11676896
[TBL] [Abstract][Full Text] [Related]
19. Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis.
Renke M; Tylicki L; Rutkowski P; Rutkowski B
Scand J Urol Nephrol; 2004; 38(5):427-33. PubMed ID: 15764256
[TBL] [Abstract][Full Text] [Related]
20. Losartan and enalapril are comparable in reducing proteinuria in children.
Webb NJ; Shahinfar S; Wells TG; Massaad R; Gleim GW; Santoro EP; Sisk CM; Lam C
Kidney Int; 2012 Oct; 82(7):819-26. PubMed ID: 22739977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
